Our Story
Our Brands
Newsroom
Investors
Contact
A lot has happened in cannabis since July 2019. That’s why the team at Canopy Rivers decided to dive deep into data powered by PitchBook to examine some big trends at the intersection of venture capital and cannabis. With the Cannabis Venture Capital Infographic, we hope to provide more clarity on private capital financing as the industry evolves.
PitchBook data shows that the amount of capital invested in cannabis-related deals has been steadily increasing since 2016. Notably, LeafLink’s US$35M Series B ranks among the top deals (by size) that took place between July and October 2019. However, metrics including median deal size and median company valuations appear to have tapered off in recent years. We see these changes as encouraging signs for the cannabis industry as the industry shifts away from high valuations that induce volatility and diminish long-term value. While the data shows that Canada and the U.S. continue to drive the majority of venture capital deal flow, it also suggests that more activity could flow to European cannabis markets in the near-term.
This is not an offer to sell or a recommendation to trade in any securities. This document contains data obtained from third parties that Canopy Rivers has not independently verified. This document also contains forward-looking information within the meaning of Canadian securities law, which is based on certain assumptions. While management believes these assumptions are reasonable based on information available as of the current date, they may prove to be incorrect. Many assumptions are based on factors outside of Canopy Rivers’ control and actual results may differ materially from current expectations. Forward-looking information involves risks, including, but not limited to, the risk factors set out in Canopy Rivers’ most recent Management’s Discussion and Analysis and Annual Information Form. You should not place undue reliance on forward-looking information. Except as required by applicable law, Canopy Rivers assumes no obligation to update or revise any forward-looking information to reflect new events or circumstances.
You can unsubscribe at any time by clicking on the unsubscribe link at the bottom of our emails. By entering your email, you are indicating your acceptance of our privacy policy and terms of use.
Please select how you would like to hear from RIV Capital:
By providing your personal information to us, you consent to our disclosure of this information to our service providers (and other third parties) as described in our privacy policy, including those that may be located outside of your jurisdiction of residence, for the purposes of processing your personal information on our behalf, providing services to us or to you, operating and hosting our website and business and for the other purposes described in our privacy policy.
We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.
Yes, I’m definitely at least twenty-one (21) years of age or am otherwise a qualified patient.